BMS logs three FDA label approvals and posts results for melanoma combo trialSep 2Weekly roundup, 5 itemsadagrasibBristol Myers Squibb
BMS registers Phase 2 depression trial for BMS-986511; adds Alzheimer's PK study for BMS-986446Aug 21Weekly roundup, 6 itemsBristol Myers Squibbentecavir
Sign inSign in